Lupin Diagnostics Launches Regional Reference Laboratory In Bengaluru

Lupin Limited (Lupin) announced the opening of a new state-of-the-art Regional Reference Laboratory in Bengaluru, Karnataka, as part of its diagnostics network expansion. The establishment of the new laboratory is a significant step forward in Lupin Diagnostics' mission to provide accessible and affordable diagnostics and preventive healthcare services throughout India. The Regional Reference Laboratory is an addition to the company's existing network of 25 laboratories and 410+ collection centres in India.

Lupin Diagnostics' new Bengaluru laboratory is outfitted with cutting-edge technologies and staffed by highly qualified clinical experts, allowing the company to provide high-quality and dependable diagnostic services to patients and consumers in Bengaluru and surrounding cities. The laboratory provides a wide range of diagnostic services, including molecular diagnostics, cytogenetics, flow cytometry, cytology, microbiology, serology, haematology, histopathology, immunology, and routine biochemistry, among others.

Lupin Diagnostics uses cutting-edge automation and streamlined processes to deliver highly accurate test results, allowing patients to make informed health decisions. "At the heart of our mission is to make quality diagnostics accessible and affordable to everyone in India," says Ravindra Kumar, CEO of Lupin Diagnostics. "We are committed to providing our patients with dependable, high-quality diagnostic services because accurate diagnosis is critical for effective disease management."

Patients and doctors can gain valuable insights into health trends and make informed treatment decisions using our cutting-edge technology and personalised smart reports," he added. Lupin Diagnostics offers doctors, patients, and consumers an unrivalled range of diagnostic services. Two of the company's laboratories have already received NABL accreditation, demonstrating the company's unwavering commitment to quality and accuracy. This achievement solidifies Lupin Diagnostics' position as a trusted leader in the healthcare industry, prioritising excellence in all that it does.

Lupin is a transnational pharmaceutical company based in Mumbai, India that focuses on innovation. The company develops and commercialises a diverse range of branded and generic formulations, biotechnology products, and APIs in over 100 markets worldwide, including the United States, India, South Africa, and Asia Pacific (APAC), Latin America (LATAM), Europe, and the Middle East.